It is a pharma private limited company based in Hyderabad, Telangana, India, established in 2012.
2012 | Hyderabad, Telangana, India | ActiveIpsum Pharmaceuticals Private Limited, a active private limited company, was established on 20 July 2012 in Hyderabad, Telangana, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24232TG2012PTC082077. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹5.00 M and a paid-up capital of ₹4.70 M.
It upholds a compliant status. Its leadership includes Palla Aparna (Director), Shyamala Budda (Director), Appala Shashikala (Director). Its latest AGM occurred on 30 November 2021, with the balance sheet filed on 31 March 2021. It is based at Plot No 101 & 102A, Road No 4, Raghavendra Nagar Bandlaguda,Nagole, Hyderabad, Telangana, 500068.
U24232TG2012PTC082077
082077
20 July 2012
₹5.00 M
₹4.70 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Ipsum Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Palla Aparna | Director | 20 Jul 2012 | Current |
| Shyamala Budda | Director | 20 Jul 2012 | Current |
| Appala Shashikala | Director | 20 Jul 2012 | Current |
| Abhishek Budda | Director | 20 Jul 2012 | Current |
| Narender Rao Kalakuntla | Director | 20 Jul 2012 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Ipsum Pharmaceuticals Private Limited, for the financial year ended 2017, experienced modest growth in revenue, with a 4.07% increase. The company also saw a slight improvement in profitability, with a 9.17% increase in profit. The company's net worth moved up by a moderate rise of 9.88%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2017, Ipsum Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Ipsum Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Ipsum Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ipsum Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Ipsum Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Nov 2021 as per latest MCA records. was recorded as a recent event.
Progress on Ipsum Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2021 with Roc Hyderabad. was documented.
The activity Palla Aparna was appointed as a Director was appointed as a Director on 20 Jul 2012 & has been associated with this company since 13 years 5 months . was completed.
Progress on Shyamala Budda was appointed as a Director was appointed as a Director on 20 Jul 2012 & has been associated with this company since 13 years 5 months . was documented.
Progress on Appala Shashikala was appointed as a Director was appointed as a Director on 20 Jul 2012 & has been associated with this company since 13 years 5 months . was documented.
The activity Abhishek Budda was appointed as a Director was appointed as a Director on 20 Jul 2012 & has been associated with this company since 13 years 5 months . was completed.
The CIN of Ipsum Pharmaceuticals Private Limited is U24232TG2012PTC082077.
Ipsum Pharmaceuticals Private Limited is headquartered at Plot No 101 & 102A, Road No 4, Raghavendra Nagar Bandlaguda,Nagole, Hyderabad, Telangana, 500068.
Ipsum Pharmaceuticals Private Limited was incorporated on 20 July 2012.
The current directors of Ipsum Pharmaceuticals Private Limited are
The primary industry of Ipsum Pharmaceuticals Private Limited is Trade.
Ipsum Pharmaceuticals Private Limited is unlisted.
The authorized capital of Ipsum Pharmaceuticals Private Limited is ₹5.00 M, and the paid-up capital is ₹4.70 M.
The compliance status of Ipsum Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX